Exchanges: BSE, NSE
Industry: Personal Care
Issue: Book building

Plethico Pharmaceuticals IPO

₹228.30

−23.90% on listing

Listing-day close · BSE · 5 May 2006 · issue price ₹300

Plethico Pharmaceuticals’ ₹110 crore IPO was priced at ₹300 a share. It listed on the BSE on 5 May 2006 and closed its first day at ₹228.30, down 23.90% on the issue price.

Timeline

Opens10 Apr 2006
Closes17 Apr 2006
Listing5 May 2006

Issue details

Issue size: ₹110 Cr
Fresh issue: ₹110 Cr
Offer for sale: —
Lot size: 20 shares
Minimum investment: ₹6,000
Face value: ₹10
Registrar: MUFG Intime India

Subscription

Plethico Pharmaceuticals IPO subscription by investor category
Category	Shares offered	Times subscribed
Total	—	25.31×

Overall, from the basis of allotment.

Financials and valuation

Market cap (post-issue): ₹1,022 Cr
Promoter holding: 97.50% → 87.01%

Financials as of 30 Sep 2005, from the offer documents.

Listing

Listing date: 5 May 2006
Issue price: ₹300
Open: ₹245.00
High: ₹300.00
Low: ₹218.10
Close: ₹228.30

Listing day on the BSE. The close was −23.90% on the issue price.

FAQs

When did the Plethico Pharmaceuticals IPO open and close?

It opened on 10 Apr 2006 and closed on 17 Apr 2006.

What was the Plethico Pharmaceuticals IPO price?

The price band was ₹280–300 a share. The final issue price was ₹300.

What is the lot size and minimum investment?

One lot is 20 shares, ₹6,000 at ₹300 a share. Retail investors apply in whole lots.

How much did Plethico Pharmaceuticals raise?

₹110 crore: ₹110 crore of new shares.

How many times was the Plethico Pharmaceuticals IPO subscribed?

25.31 times overall.

How did Plethico Pharmaceuticals list?

It listed on the BSE on 5 May 2006 at ₹245.00 and closed the day at ₹228.30, down 23.90% on the ₹300 issue price.

Who is the registrar of the Plethico Pharmaceuticals IPO?

MUFG Intime India handles the allotment, refunds and credit of shares.

For information only. Not investment advice or a research report.

Full disclaimer

See how an IPO fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app